Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

86
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
86
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

43
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
43

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in the Study of Acute Necrotizing Encephalopathy.

Infection and drug resistance·2025
Same author

[Application Test of the AI-Automatic Diagnostic System for Ki-67 in Breast Cancer].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·2021
Same author

Investigation of diarrhetic shellfish toxins in Lingshan Bay, Yellow Sea, China, using solid-phase adsorption toxin tracking (SPATT).

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment·2016
Same author

[Long-term plasticity of HVC-RA synapses in adult male zebra finches].

Sheng li xue bao : [Acta physiologica Sinica]·2013
Same author

[Pilot observation on the effect of integrated control measures against clonorchiasis in Pengjiang District of Jiangmen City].

Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases·2012
Same author

[Development of clinical trials for acupuncture treatment of common illnesses or clinical conditions in countries outside China].

Zhen ci yan jiu = Acupuncture research·2012

Related Experiment Video

Updated: May 28, 2025

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
12:14

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

34.9K

Inflammatory markers in acute ischemic stroke.

Zi-Jie Cao1, Qian-Xuan Wang1, Yi Sun1

  • 1Department of Neurology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang 261000 China.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|February 10, 2025
PubMed
Summary
This summary is machine-generated.

Serum inflammatory markers are key indicators for acute ischemic stroke (AIS) severity and prognosis. Monitoring these markers can improve diagnosis, treatment, and patient outcomes.

Keywords:
Acute phase responseAnti-inflammationInflammationIschemic strokePathogenesisPrognosis

More Related Videos

Stereological and Flow Cytometry Characterization of Leukocyte Subpopulations in Models of Transient or Permanent Cerebral Ischemia
12:42

Stereological and Flow Cytometry Characterization of Leukocyte Subpopulations in Models of Transient or Permanent Cerebral Ischemia

Published on: December 28, 2014

15.6K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.6K

Related Experiment Videos

Last Updated: May 28, 2025

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
12:14

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

34.9K
Stereological and Flow Cytometry Characterization of Leukocyte Subpopulations in Models of Transient or Permanent Cerebral Ischemia
12:42

Stereological and Flow Cytometry Characterization of Leukocyte Subpopulations in Models of Transient or Permanent Cerebral Ischemia

Published on: December 28, 2014

15.6K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.6K

Area of Science:

  • Neurology
  • Immunology
  • Biochemistry

Background:

  • Acute ischemic stroke (AIS) is a leading cause of disability.
  • Understanding AIS pathogenesis is crucial for effective treatment.

Purpose of the Study:

  • To review the role of serum inflammatory markers in AIS pathogenesis and prognosis.
  • To enhance understanding of AIS mechanisms for better diagnosis and treatment.

Main Methods:

  • Quantitative analysis of serum inflammatory markers in AIS patients.
  • Correlation analysis between marker levels, disease severity, and outcomes.

Main Results:

  • Serum inflammatory markers correlate strongly with AIS severity and progression.
  • Markers predict functional recovery and recurrence risk.
  • Elevated matrix metalloproteinases-9 (MMP-9) increased disability/mortality risk by 16% per 0.32 ng/mL increase.

Conclusions:

  • Inflammatory markers offer insights into AIS pathophysiology.
  • These markers can guide early diagnosis, disease assessment, and personalized treatment.
  • Monitoring inflammatory markers supports precision medicine for AIS.